Treatment of acute hepatitis C infection: more pieces of the puzzle?
- 31 March 2005
- journal article
- editorial
- Published by Elsevier in Journal of Hepatology
- Vol. 42 (3) , 293-296
- https://doi.org/10.1016/j.jhep.2004.12.012
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Barriers to interferon-α therapy are higher in intravenous drug users than in other patients with acute hepatitis CJournal of Hepatology, 2005
- Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearanceJournal of Hepatology, 2004
- Pegylated interferon α therapy in acute hepatitis C: Relation to hepatitis C virus-specific T cell response kineticsHepatology, 2004
- Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trialHepatology, 2004
- 250 24 weeks of monotherapy with pegylated interferon alfa-2B in patients with acute hepatitis CHepatology, 2003
- Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance1 1The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication.Gastroenterology, 2003
- Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral loadHepatology, 2003
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001
- Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term OutcomeSeminars in Liver Disease, 2000
- Estimating future hepatitis C morbidity, mortality, and costs in the United StatesAmerican Journal of Public Health, 2000